ATARA BIOTHERAPEUTICS, INC. COMMON STOCK SALES AGREEMENTCommon Stock • November 1st, 2023 • Atara Biotherapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledNovember 1st, 2023 Company Industry JurisdictionAtara Biotherapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
CUE HEALTH INC. COMMON STOCK SALES AGREEMENTCommon Stock • August 9th, 2023 • Cue Health Inc. • Laboratory analytical instruments • New York
Contract Type FiledAugust 9th, 2023 Company Industry JurisdictionCue Health Inc., a Delaware corporation, (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
SERES THERAPEUTICS, INC. COMMON STOCK SALES AGREEMENTCommon Stock • August 8th, 2023 • Seres Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 8th, 2023 Company Industry Jurisdiction
AN2 THERAPEUTICS, INC. COMMON STOCK SALES AGREEMENTCommon Stock • April 6th, 2023 • AN2 Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 6th, 2023 Company Industry Jurisdiction
HOMOLOGY MEDICINES, INC. COMMON STOCK SALES AGREEMENTCommon Stock • March 9th, 2023 • Homology Medicines, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 9th, 2023 Company Industry Jurisdiction
IO BIOTECH, INC. COMMON STOCK SALES AGREEMENTCommon Stock • February 15th, 2023 • IO Biotech, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 15th, 2023 Company Industry Jurisdiction
23ANDME HOLDING CO. COMMON STOCK SALES AGREEMENTCommon Stock • February 6th, 2023 • 23andMe Holding Co. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 6th, 2023 Company Industry Jurisdiction
EVELO BIOSCIENCES, INC. COMMON STOCK SALES AGREEMENTCommon Stock • July 1st, 2022 • Evelo Biosciences, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJuly 1st, 2022 Company Industry Jurisdiction
KYMERA THERAPEUTICS, INC. COMMON STOCK SALES AGREEMENTCommon Stock • October 1st, 2021 • Kymera Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledOctober 1st, 2021 Company Industry JurisdictionKymera Therapeutics, Inc. (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
SERES THERAPEUTICS, INC. COMMON STOCK SALES AGREEMENTCommon Stock • May 21st, 2021 • Seres Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 21st, 2021 Company Industry Jurisdiction
ADVERUM BIOTECHNOLOGIES, INC. COMMON STOCK SALES AGREEMENTCommon Stock • December 17th, 2020 • Adverum Biotechnologies, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledDecember 17th, 2020 Company Industry JurisdictionAdverum Biotechnologies, Inc. (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
HOMOLOGY MEDICINES, INC. COMMON STOCK SALES AGREEMENTCommon Stock • March 12th, 2020 • Homology Medicines, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 12th, 2020 Company Industry Jurisdiction
MACROGENICS, INC. COMMON STOCK SALES AGREEMENTCommon Stock • December 23rd, 2019 • Macrogenics Inc • Pharmaceutical preparations • New York
Contract Type FiledDecember 23rd, 2019 Company Industry JurisdictionMacroGenics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
SERES THERAPEUTICS, INC. COMMON STOCK SALES AGREEMENTCommon Stock • November 27th, 2019 • Seres Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 27th, 2019 Company Industry Jurisdiction
GRITSTONE ONCOLOGY, INC. COMMON STOCK SALES AGREEMENTCommon Stock • October 15th, 2019 • Gritstone Oncology, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledOctober 15th, 2019 Company Industry JurisdictionGritstone Oncology, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
SUTRO BIOPHARMA, INC. COMMON STOCK SALES AGREEMENTCommon Stock • October 4th, 2019 • Sutro Biopharma, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledOctober 4th, 2019 Company Industry Jurisdiction
MAGENTA THERAPEUTICS, INC. COMMON STOCK SALES AGREEMENTCommon Stock • August 8th, 2019 • Magenta Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 8th, 2019 Company Industry JurisdictionMagenta Therapeutics, Inc. (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
OTONOMY, INC. COMMON STOCK SALES AGREEMENTCommon Stock • August 1st, 2019 • Otonomy, Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 1st, 2019 Company Industry Jurisdiction
AVROBIO, INC. COMMON STOCK SALES AGREEMENTCommon Stock • July 1st, 2019 • AVROBIO, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledJuly 1st, 2019 Company Industry Jurisdiction
APTINYX INC. COMMON STOCK SALES AGREEMENTCommon Stock • July 1st, 2019 • Aptinyx Inc. • Pharmaceutical preparations • New York
Contract Type FiledJuly 1st, 2019 Company Industry Jurisdiction
EVELO BIOSCIENCES, INC. COMMON STOCK SALES AGREEMENTCommon Stock • June 3rd, 2019 • Evelo Biosciences, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJune 3rd, 2019 Company Industry JurisdictionThe Company has filed or will file, in accordance with the provisions of the Securities Act of 1933, as amended, and the rules and regulations thereunder (collectively, the "Securities Act"), with the Commission a registration statement on Form S-3, including (a) a base prospectus, relating to certain securities, including the Common Stock, to be issued from time to time by the Company, and which incorporates by reference documents that the Company has filed or will file in accordance with the provisions of the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (collectively, the "Exchange Act") and (b) a prospectus supplement specifically relating to the Placement Shares (the "Prospectus Supplement") to the base prospectus included as part of such registration statement. The Company has furnished to Cowen, for use by Cowen, copies of the prospectus included as part of such registration statement, as supplemented by the Prospectus Supplement, relating
UNITY BIOTECHNOLOGY, INC. $75,000,000 SHARES OF COMMON STOCK SALES AGREEMENTCommon Stock • June 3rd, 2019 • Unity Biotechnology, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJune 3rd, 2019 Company Industry JurisdictionUnity Biotechnology, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
UNUM THERAPEUTICS INC. COMMON STOCK SALES AGREEMENTCommon Stock • April 2nd, 2019 • Unum Therapeutics Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 2nd, 2019 Company Industry Jurisdiction
HOMOLOGY MEDICINES, INC. COMMON STOCK SALES AGREEMENTCommon Stock • April 1st, 2019 • Homology Medicines, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 1st, 2019 Company Industry Jurisdiction
HTG MOLECULAR DIAGNOSTICS, INC. COMMON STOCK SALES AGREEMENTCommon Stock • March 13th, 2019 • HTG Molecular Diagnostics, Inc • Laboratory analytical instruments • New York
Contract Type FiledMarch 13th, 2019 Company Industry JurisdictionHTG Molecular Diagnostics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
CHIASMA, INC. COMMON STOCK SALES AGREEMENTCommon Stock • November 8th, 2018 • Chiasma, Inc • Pharmaceutical preparations • New York
Contract Type FiledNovember 8th, 2018 Company Industry Jurisdiction
CTI BIOPHARMA CORP. COMMON STOCK SALES AGREEMENTCommon Stock • November 1st, 2018 • Cti Biopharma Corp • Pharmaceutical preparations • New York
Contract Type FiledNovember 1st, 2018 Company Industry JurisdictionCTI BioPharma Corp., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
INVITAE CORPORATION COMMON STOCK SALES AGREEMENTCommon Stock • August 10th, 2018 • Invitae Corp • Services-medical laboratories • New York
Contract Type FiledAugust 10th, 2018 Company Industry JurisdictionInvitae Corporation, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
SIENNA BIOPHARMACEUTICALS, INC. COMMON STOCK SALES AGREEMENTCommon Stock • August 3rd, 2018 • Sienna Biopharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 3rd, 2018 Company Industry JurisdictionSienna Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
DICERNA PHARMACEUTICALS, INC. COMMON STOCK SALES AGREEMENTCommon Stock • May 17th, 2018 • Dicerna Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledMay 17th, 2018 Company Industry JurisdictionDicerna Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
RECRO PHARMA, INC. COMMON STOCK SALES AGREEMENTCommon Stock • December 29th, 2017 • Recro Pharma, Inc. • Pharmaceutical preparations • New York
Contract Type FiledDecember 29th, 2017 Company Industry Jurisdiction
ANTARES PHARMA, INC. COMMON STOCK SALES AGREEMENTCommon Stock • August 11th, 2017 • Antares Pharma, Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledAugust 11th, 2017 Company Industry Jurisdiction
ADVERUM BIOTECHNOLOGIES, INC. COMMON STOCK SALES AGREEMENTCommon Stock • August 10th, 2017 • Adverum Biotechnologies, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 10th, 2017 Company Industry JurisdictionAdverum Biotechnologies, Inc. (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
VERSARTIS, INC. COMMON STOCK SALES AGREEMENTCommon Stock • August 10th, 2017 • Versartis, Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 10th, 2017 Company Industry JurisdictionVersartis, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
CALITHERA BIOSCIENCES, INC. COMMON STOCK SALES AGREEMENTCommon Stock • August 8th, 2017 • Calithera Biosciences, Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 8th, 2017 Company Industry JurisdictionCalithera Biosciences, Inc. (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows: